{"id":"https://openalex.org/W2910179486","doi":"https://doi.org/10.1177/1074248418817345","title":"The Role of Vildagliptin in Treating Hypertension Through Modulating Serum VEGF in Diabetic Hypertensive Patients","display_name":"The Role of Vildagliptin in Treating Hypertension Through Modulating Serum VEGF in Diabetic Hypertensive Patients","publication_year":2019,"publication_date":"2019-01-10","ids":{"openalex":"https://openalex.org/W2910179486","doi":"https://doi.org/10.1177/1074248418817345","mag":"2910179486","pmid":"https://pubmed.ncbi.nlm.nih.gov/30630371"},"language":"en","primary_location":{"id":"doi:10.1177/1074248418817345","doi":"https://doi.org/10.1177/1074248418817345","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1074248418817345","pdf_url":null,"source":{"id":"https://openalex.org/S130832228","display_name":"Journal of Cardiovascular Pharmacology and Therapeutics","issn_l":"1074-2484","issn":["1074-2484","1940-4034"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology and Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038324181","display_name":"Abdel Rahman El-Naggar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145487455","display_name":"Cairo University","ror":"https://ror.org/03q21mh05","country_code":"EG","type":"education","lineage":["https://openalex.org/I145487455"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Abdel Rahman El-Naggar","raw_affiliation_strings":["Department of Medical Pharmacology, Faculty of Medicine, Cairo University, Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Pharmacology, Faculty of Medicine, Cairo University, Cairo, Egypt","institution_ids":["https://openalex.org/I145487455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036650762","display_name":"Dalia K. Zaafar","orcid":"https://orcid.org/0000-0002-7201-3658","observed_orcids":["https://orcid.org/0000-0002-7201-3658"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Dalia Zaafar","raw_affiliation_strings":["Department of Pharmacology and Toxicology, Faculty of Pharmacy, MTI University, Cairo, Egypt"],"raw_orcid":"https://orcid.org/0000-0002-7201-3658","affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, MTI University, Cairo, Egypt","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112520617","display_name":"Mohammed F. El-Yamany","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145487455","display_name":"Cairo University","ror":"https://ror.org/03q21mh05","country_code":"EG","type":"education","lineage":["https://openalex.org/I145487455"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Mohammed Elyamany","raw_affiliation_strings":["Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt","institution_ids":["https://openalex.org/I145487455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057587563","display_name":"Soha Osama Hassanin","orcid":"https://orcid.org/0000-0001-8568-1033","observed_orcids":["https://orcid.org/0000-0001-8568-1033"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Soha Hassanin","raw_affiliation_strings":["Department of Biochemistry, Faculty of pharmacy, MTI University, Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry, Faculty of pharmacy, MTI University, Cairo, Egypt","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004772094","display_name":"Atef Bassyouni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Atef Bassyouni","raw_affiliation_strings":["National Institute of Diabetes and Endocrinology, Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute of Diabetes and Endocrinology, Cairo, Egypt","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110698900","display_name":"H. Abdellatif","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145487455","display_name":"Cairo University","ror":"https://ror.org/03q21mh05","country_code":"EG","type":"education","lineage":["https://openalex.org/I145487455"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Hekma Abdel-Latif","raw_affiliation_strings":["Faculty of pharmacy, Cairo University, Giza, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of pharmacy, Cairo University, Giza, Egypt","institution_ids":["https://openalex.org/I145487455"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5036650762"],"corresponding_institution_ids":[],"apc_list":{"value":1325,"currency":"USD","value_usd":1325},"apc_paid":null,"fwci":0.6588,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.73922827,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"24","issue":"3","first_page":"254","last_page":"261"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7324000000953674,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7324000000953674,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.20239999890327454,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.015599999576807022,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vildagliptin","display_name":"vildagliptin","score":1.0},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.847000002861023},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7179999947547913},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8489999771118164},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.9449999928474426},{"id":"https://openalex.org/keywords/endothelial-function","display_name":"endothelial function","score":0.9679999947547913},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.8109999895095825},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9380000233650208},{"id":"https://openalex.org/keywords/captopril","display_name":"captopril","score":0.8870000243186951},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.7210000157356262},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.6520000100135803},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.7260000109672546},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.7549999952316284},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9789999723434448}],"concepts":[{"id":"https://openalex.org/C2776453732","wikidata":"https://www.wikidata.org/wiki/Q421042","display_name":"Vildagliptin","level":4,"score":0.9495494365692139},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9217301607131958},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.8428803086280823},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.6890684366226196},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6707279086112976},{"id":"https://openalex.org/C2779479957","wikidata":"https://www.wikidata.org/wiki/Q421119","display_name":"Captopril","level":3,"score":0.6526632905006409},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5810962319374084},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.571255624294281},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.54903244972229},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.5258225202560425},{"id":"https://openalex.org/C2778270857","wikidata":"https://www.wikidata.org/wiki/Q2723972","display_name":"Lipid profile","level":3,"score":0.5131695866584778},{"id":"https://openalex.org/C156490143","wikidata":"https://www.wikidata.org/wiki/Q412214","display_name":"Dipeptidyl peptidase-4","level":4,"score":0.49294114112854004},{"id":"https://openalex.org/C2777538456","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated hemoglobin","level":4,"score":0.48491746187210083},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4526819586753845},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.4376308023929596},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3573005199432373},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.12423235177993774}],"mesh":[{"descriptor_ui":"D000077597","descriptor_name":"Vildagliptin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000077597","descriptor_name":"Vildagliptin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002216","descriptor_name":"Captopril","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002216","descriptor_name":"Captopril","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004534","descriptor_name":"Egypt","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D007333","descriptor_name":"Insulin Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/1074248418817345","doi":"https://doi.org/10.1177/1074248418817345","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1074248418817345","pdf_url":null,"source":{"id":"https://openalex.org/S130832228","display_name":"Journal of Cardiovascular Pharmacology and Therapeutics","issn_l":"1074-2484","issn":["1074-2484","1940-4034"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology and Therapeutics","raw_type":"journal-article"},{"id":"pmid:30630371","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30630371","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cardiovascular pharmacology and therapeutics","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1248783087","https://openalex.org/W1487032696","https://openalex.org/W1981473523","https://openalex.org/W1987981915","https://openalex.org/W1999472447","https://openalex.org/W2023315412","https://openalex.org/W2060698866","https://openalex.org/W2102945856","https://openalex.org/W2160088494","https://openalex.org/W2473154804","https://openalex.org/W2508590412","https://openalex.org/W2585596078","https://openalex.org/W2601416250","https://openalex.org/W2611003948","https://openalex.org/W2917198334","https://openalex.org/W4239837977","https://openalex.org/W4292528167"],"related_works":["https://openalex.org/W2886806906","https://openalex.org/W1845549469","https://openalex.org/W7096528141","https://openalex.org/W2762278797","https://openalex.org/W3085661795","https://openalex.org/W2943922773","https://openalex.org/W3123027842","https://openalex.org/W7217361904","https://openalex.org/W7099660734","https://openalex.org/W2593611359"],"abstract_inverted_index":{"Background:":[0],"Several":[1],"trials":[2],"have":[3],"reported":[4],"that":[5,145],"dipeptidyl":[6],"peptidase-4":[7],"(DPP-4)":[8],"inhibitors":[9],"are":[10],"used":[11],"to":[12,18,35,96,105,117,215],"improve":[13],"endothelial":[14,38,45],"function":[15,39],"in":[16,50,94,103,110,115,213,226],"addition":[17,95,104,116,214],"treating":[19],"type":[20],"2":[21],"diabetes":[22],"(T2DM).":[23],"The":[24,107],"current":[25],"study":[26,58],"investigated":[27],"the":[28,136,139,142,217],"effects":[29],"of":[30,69,138,220],"vildagliptin,":[31],"DPP-4":[32],"inhibitor,":[33],"compared":[34],"metformin":[36,157,223],"on":[37],"and":[40,54,74,86,98,131,151,182,186,191,207,211],"blood":[41,121,149,200],"pressure":[42,150],"through":[43,174,198],"vascular":[44],"growth":[46],"factor":[47],"(VEGF)":[48],"modulation":[49],"patients":[51,81,88,99],"with":[52,84,90,101,167],"T2DM":[53],"hypertension.":[55],"Methods:":[56],"This":[57],"was":[59,113,158,224],"designed":[60],"as":[61],"a":[62,171,195],"randomized":[63],"controlled":[64],"parallel":[65],"study.":[66],"A":[67],"total":[68,128],"120":[70],"volunteers":[71],"were":[72],"recruited":[73],"allocated":[75],"into":[76],"4":[77],"groups:":[78],"healthy":[79],"volunteers,":[80],"recently":[82],"diagnosed":[83],"hypertension":[85,93],"diabetes,":[87],"treated":[89,100],"captopril":[91,102],"for":[92],"metformin,":[97,168],"vildagliptin.":[106],"percentage":[108],"change":[109],"body":[111,163,228],"weight":[112],"calculated":[114],"serum":[118,153],"VEGF":[119,154,180,205],"levels,":[120,155],"pressure,":[122],"glycated":[123],"hemoglobin":[124],"(HbA":[125],"1c":[126],"),":[127],"lipid":[129,218],"profile,":[130],"insulin":[132],"resistance.":[133],"Results:":[134],"At":[135],"end":[137],"therapeutic":[140],"period,":[141],"results":[143],"showed":[144,170,194],"vildagliptin":[146,169],"significantly":[147],"decreased":[148],"increased":[152],"while":[156,222],"more":[159],"effective":[160],"at":[161],"lowering":[162],"weight.":[164,229],"In":[165],"comparison":[166],"promising":[172,196],"action":[173,197],"its":[175,199],"antihypertensive":[176],"effect":[177,202],"via":[178,203],"elevating":[179],"levels":[181,206],"improving":[183,208,216],"physiological":[184,209],"angiogenesis":[185,210],"vasculature.":[187],"What":[188],"is":[189],"new":[190],"conclusion:":[192],"Vildagliptin":[193],"pressure-regulating":[201],"modulating":[204],"vasculature,":[212],"profile":[219],"patients,":[221],"better":[225],"reducing":[227]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-01-25T00:00:00"}